| Mass Optometric Associates, Pllc | |
|
1 Highland Ave, 3b, Malden, MA 02148-6603 | |
| (781) 321-9039 | |
| (781) 321-8611 |
| Full Name | Mass Optometric Associates, Pllc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1 Highland Ave, Malden, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063610194 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Leonard Bertoli |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1477504538 PECOS PAC ID: 5799678348 Enrollment ID: I20040206000088 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Sandra J White |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1205886355 PECOS PAC ID: 7517938392 Enrollment ID: I20040804001256 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Deborah M L Zopatti |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1053393025 PECOS PAC ID: 2961452651 Enrollment ID: I20050131000490 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Cynthia A Normandie |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1801972229 PECOS PAC ID: 0244286029 Enrollment ID: I20050324000491 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Christopher R Brown |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1932167939 PECOS PAC ID: 5496775496 Enrollment ID: I20051206000548 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Elizabeth Js Redman |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1750332839 PECOS PAC ID: 7618998824 Enrollment ID: I20051215000622 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Shannon L Mccann |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1437193299 PECOS PAC ID: 2860413077 Enrollment ID: I20051215000648 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Esther M Morales |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1588720437 PECOS PAC ID: 1355365743 Enrollment ID: I20060125000058 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Richard A Hartwell |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1679525968 PECOS PAC ID: 2466451927 Enrollment ID: I20061211000198 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Debra O Cohen |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1245307834 PECOS PAC ID: 7315949070 Enrollment ID: I20070208000416 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Kelly A Bado |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1124213616 PECOS PAC ID: 5193805430 Enrollment ID: I20071228000051 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Fotini Kostogiannis |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1689855892 PECOS PAC ID: 4789767229 Enrollment ID: I20080207000262 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Robert Kupsc |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1780724187 PECOS PAC ID: 4587742481 Enrollment ID: I20080417000321 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Dale D Morris |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1952315558 PECOS PAC ID: 6507931078 Enrollment ID: I20080829000121 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Melissa J Butler |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1699818922 PECOS PAC ID: 0244398469 Enrollment ID: I20081016000440 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Bruce L Rakusin |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1952348534 PECOS PAC ID: 2365501897 Enrollment ID: I20081112000500 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | H David Tabaie |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1124004247 PECOS PAC ID: 9032279542 Enrollment ID: I20081113000422 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Steven M Strojny |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1861439440 PECOS PAC ID: 6709946767 Enrollment ID: I20081120000273 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Sally T Carlos |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1174688816 PECOS PAC ID: 0244319507 Enrollment ID: I20081211000259 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Margaret Mary Johnson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1902052327 PECOS PAC ID: 4284797028 Enrollment ID: I20090106000239 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Robert M Golden |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1801907811 PECOS PAC ID: 6709940331 Enrollment ID: I20090127000430 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Darina Polsonetti |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1245496009 PECOS PAC ID: 6608923719 Enrollment ID: I20090407000312 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Sivhour Ly |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1346498029 PECOS PAC ID: 5496804098 Enrollment ID: I20090529000470 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Chad E Mcdonald |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1215909643 PECOS PAC ID: 4981734134 Enrollment ID: I20100614000854 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Caroline Perriello Consigli |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1518282193 PECOS PAC ID: 6002946035 Enrollment ID: I20100617000279 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Roger Mccarthy |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1487662409 PECOS PAC ID: 9032243522 Enrollment ID: I20100819000545 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | David J Conway |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1831255702 PECOS PAC ID: 9032301270 Enrollment ID: I20101007000032 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Randi V Frankl |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1265749642 PECOS PAC ID: 0547457210 Enrollment ID: I20101207000547 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Patricia Lyn Hazell |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1154453199 PECOS PAC ID: 7012813264 Enrollment ID: I20110211000451 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Blair Francis O'reilly |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1275848509 PECOS PAC ID: 6507041472 Enrollment ID: I20110420000124 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Santanu Mukherjee |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1396817599 PECOS PAC ID: 8729251251 Enrollment ID: I20111028000498 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Susan Senna Cheng |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1629358346 PECOS PAC ID: 5991978421 Enrollment ID: I20111028000517 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Jad Osmanski |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1447402821 PECOS PAC ID: 3870775471 Enrollment ID: I20111121000850 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Kristen H Behrens |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1730434754 PECOS PAC ID: 8921250036 Enrollment ID: I20121218000034 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Kristina L I Lazar |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1962758581 PECOS PAC ID: 9739332339 Enrollment ID: I20130110000074 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Beth B Chenier |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1467793356 PECOS PAC ID: 9133362056 Enrollment ID: I20130826000233 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Shirley Salomon |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1336580901 PECOS PAC ID: 9335375351 Enrollment ID: I20131122000156 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Phuong T Nguyen |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1164855698 PECOS PAC ID: 5991933004 Enrollment ID: I20140117001654 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Amanda M Hunter |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1114368164 PECOS PAC ID: 3375772106 Enrollment ID: I20140127001276 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Vivian C Schaefer |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1447691118 PECOS PAC ID: 7113160482 Enrollment ID: I20140325000088 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Mai-khuyen Nguyen |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1407297815 PECOS PAC ID: 4183849748 Enrollment ID: I20140715002623 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Michael S Henderson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1174589592 PECOS PAC ID: 7012942147 Enrollment ID: I20140825000542 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Christina M Herald |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1831504133 PECOS PAC ID: 8527286988 Enrollment ID: I20140826001985 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | John T Leffers |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1235369349 PECOS PAC ID: 7012137847 Enrollment ID: I20140930000960 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Alexandra Reznitsky |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1427457787 PECOS PAC ID: 1153543814 Enrollment ID: I20141112002152 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Minsheng Yuan |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1275938284 PECOS PAC ID: 0840516878 Enrollment ID: I20150331001260 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Niloofar Montazer Rahmati |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1780073767 PECOS PAC ID: 6901125699 Enrollment ID: I20150430001430 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Emma Chu |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1376926311 PECOS PAC ID: 6901114438 Enrollment ID: I20151002002450 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Donna Zhang |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1588046783 PECOS PAC ID: 7214246255 Enrollment ID: I20151014001680 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Afsoon Takrimi |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1477920718 PECOS PAC ID: 6507166360 Enrollment ID: I20151130001360 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Yanpeng Ding |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1053780692 PECOS PAC ID: 9638472871 Enrollment ID: I20160122000759 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Dina Kuch-pierce |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1376902627 PECOS PAC ID: 2466742713 Enrollment ID: I20160527001706 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Thuong M Tran |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1750743340 PECOS PAC ID: 7911290663 Enrollment ID: I20160719000739 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Jennifer L Boggie |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1356587976 PECOS PAC ID: 5799008793 Enrollment ID: I20160920002075 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Jia Jiann Liaw |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1609327774 PECOS PAC ID: 1153601208 Enrollment ID: I20161206001843 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Greg Waldorf |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1386709947 PECOS PAC ID: 1759355845 Enrollment ID: I20170213000674 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Lily Mac |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1508022021 PECOS PAC ID: 6204999006 Enrollment ID: I20171109000567 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Hope Elizabeth Rittichier |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1770984684 PECOS PAC ID: 8628298676 Enrollment ID: I20171201000036 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Leah R Soll |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1770009490 PECOS PAC ID: 3577823079 Enrollment ID: I20180201000259 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Shruti S Ravula |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1336599950 PECOS PAC ID: 1658634571 Enrollment ID: I20180406000021 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Paul Robert Tieri |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1245720655 PECOS PAC ID: 9234489378 Enrollment ID: I20180911001152 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Felicia M Dupras |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1588194732 PECOS PAC ID: 0143572347 Enrollment ID: I20181017000999 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Nimira Samji |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1235204694 PECOS PAC ID: 7315283868 Enrollment ID: I20190104000601 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Randal Harrison White |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1043785207 PECOS PAC ID: 5294071411 Enrollment ID: I20190109001581 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Kristen Peterson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1922577469 PECOS PAC ID: 2466799390 Enrollment ID: I20190130001133 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Marina Grinspan |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1831105691 PECOS PAC ID: 1153450424 Enrollment ID: I20190522002512 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Fatima Bukhari |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1790019743 PECOS PAC ID: 0648319715 Enrollment ID: I20190822002603 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Thao Dung |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1558438101 PECOS PAC ID: 9335179522 Enrollment ID: I20190829002404 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Brianna Tran |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1396306718 PECOS PAC ID: 5991032799 Enrollment ID: I20191015001488 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Vivek Mallampalli |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1629636550 PECOS PAC ID: 8820320567 Enrollment ID: I20191029002526 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Jayasree Seshadri |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1215167879 PECOS PAC ID: 2264588854 Enrollment ID: I20191217000891 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Dora Pepo |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1942859780 PECOS PAC ID: 6002247822 Enrollment ID: I20200512001457 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Lisha Patel |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1023636834 PECOS PAC ID: 7719305754 Enrollment ID: I20200908002939 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Zachary W Sousa |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1578182192 PECOS PAC ID: 6800214149 Enrollment ID: I20200917002213 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Sandra Sawa |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1376712521 PECOS PAC ID: 2860803285 Enrollment ID: I20201116001635 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Zhen Zhen Gao |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1194379115 PECOS PAC ID: 7810301280 Enrollment ID: I20210126000822 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Yu-qiong Niu |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1063086874 PECOS PAC ID: 2860893229 Enrollment ID: I20210623002633 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Josephine W Ko |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1053934935 PECOS PAC ID: 8426453978 Enrollment ID: I20210820001136 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Thuy Nguyen |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1811517899 PECOS PAC ID: 9537567003 Enrollment ID: I20211013003327 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Natasha H Siegel |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1710573118 PECOS PAC ID: 1456741263 Enrollment ID: I20211210001050 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Ariadne Rowe |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1245983550 PECOS PAC ID: 6507241577 Enrollment ID: I20220913000701 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Taylor Ashlin Canamore |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1902524077 PECOS PAC ID: 3375928633 Enrollment ID: I20220922001854 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Mickael David Kaculini |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1598429219 PECOS PAC ID: 1254707912 Enrollment ID: I20221020001574 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Ashley Wallace |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1770217267 PECOS PAC ID: 3476929175 Enrollment ID: I20221020003274 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Michelle Gong |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1912674961 PECOS PAC ID: 4082084348 Enrollment ID: I20221230001579 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Charles Albert Milhoan |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1083311732 PECOS PAC ID: 9335513852 Enrollment ID: I20230324000985 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Jenifer Bui |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1295431054 PECOS PAC ID: 7719352079 Enrollment ID: I20230419000785 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Ashley Bascom |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1104496702 PECOS PAC ID: 4082079637 Enrollment ID: I20230503002487 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Provider Name | Merve Tuccar Burak |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1356034250 PECOS PAC ID: 9830543685 Enrollment ID: I20230927001890 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mass Optometric Associates, Pllc Po Box 417821, Boston, MA 02241-7821 Ph: (800) 340-0129 | Mass Optometric Associates, Pllc 1 Highland Ave, 3b, Malden, MA 02148-6603 Ph: (781) 321-9039 |
News Archive
With its focus on Medicare plans for the elderly, Humana Inc believes it can grow with the wave of aging baby boomers without moving far afield from its main customer base of seniors.
It's known that cholesterol levels typically rise as people age and that high cholesterol levels are associated with increased risk of cardiovascular disease. What's less known is that cholesterol levels begin to decline the more a person ages. Recently, researchers from the University of Texas Medical Branch at Galveston and the University of Kentucky found that differences in one gene can influence a person's cholesterol levels from midlife to late life.
Currently, no possibility exists to reliably quantify the risk of Alzheimer's disease (AD) onset in the general population and in subjects with mild cognitive impairment.
Sosei Group Corporation, confirms the information released today by Novartis that the first three QVA149 Phase III studies in the treatment of chronic obstructive pulmonary disease (COPD) all met their primary endpoints.
› Verified 5 days ago
Dr. Keith Paul Andrews, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 103 Pleasant St, Malden, MA 02148 Phone: 781-397-8213 Fax: 781-397-8213 | |
Inn Jee Park, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1 Highland Ave # 3b, Mass Optometric Associates, P.c., Malden, MA 02148 Phone: 781-321-9039 Fax: 781-321-8611 | |
Grace Ho, Optometrist Medicare: Not Enrolled in Medicare Practice Location: 555 Main St, Malden, MA 02148 Phone: 857-399-3870 | |
In Vision Boston Optometrist Medicare: Medicare Enrolled Practice Location: 216 Centre St, Malden, MA 02148 Phone: 781-321-8883 Fax: 781-321-8882 | |
Guang-ji Wang Optometrist Medicare: Not Enrolled in Medicare Practice Location: 629 Main St, Malden, MA 02148 Phone: 781-321-6989 | |
Dr. Deborah Wayne Optometrist Medicare: Not Enrolled in Medicare Practice Location: 702 Salem St, Malden, MA 02148 Phone: 781-321-3222 Fax: 781-324-2922 |